BlackRock’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

BlackRock’s Portfolio SYNH Stock Details SYNH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-9,930,430	Closed	-$418M	–	5564
2023 Q2	$418M	Sell	9,930,430 -575,313	-5%	-$23.3M	0.01%	1060
2023 Q1	$374M	Sell	10,505,743 -524,633	-5%	-$19M	0.01%	1116
2022 Q4	$405M	Buy	11,030,376 +453,025	+4%	+$17.9M	0.01%	1031
2022 Q3	$499M	Sell	10,577,351 -972,626	-8%	-$62.8M	0.02%	820
2022 Q2	$828M	Buy	11,549,977 +22,197	+0.2%	+$1.62M	0.03%	583
2022 Q1	$933M	Buy	11,527,780 +1,617,330	+16%	+$137M	0.03%	611
2021 Q4	$1.02B	Buy	9,910,450 +707,665	+8%	+$68M	0.03%	601
2021 Q3	$805M	Buy	9,202,785 +109,566	+1%	+$9.92M	0.02%	673
2021 Q2	$814M	Buy	9,093,219 +776,240	+9%	+$65.6M	0.02%	696
2021 Q1	$631M	Buy	8,316,979 +844,278	+11%	+$63.6M	0.02%	822
2020 Q4	$509M	Buy	7,472,701 +387,785	+5%	+$24.2M	0.02%	882
2020 Q3	$377M	Buy	7,084,916 +75,715	+1%	+$4.51M	0.01%	919
2020 Q2	$408M	Sell	7,009,201 -1,510,412	-18%	-$81.2M	0.02%	843
2020 Q1	$336M	Sell	8,519,613 -322,050	-4%	-$18.8M	0.02%	824
2019 Q4	$526M	Buy	8,841,663 +69,698	+0.8%	+$3.75M	0.02%	768
2019 Q3	$467M	Buy	8,771,965 +238,015	+3%	+$12.2M	0.02%	803
2019 Q2	$436M	Buy	8,533,950 +172,529	+2%	+$8.03M	0.02%	837
2019 Q1	$433M	Sell	8,361,421 -99,843	-1%	-$4.84M	0.02%	826
2018 Q4	$333M	Buy	8,461,264 +425,338	+5%	+$19.8M	0.02%	911
2018 Q3	$414M	Buy	8,035,926 +751,050	+10%	+$36.8M	0.02%	891
2018 Q2	$342M	Buy	7,284,876 +213,185	+3%	+$8.82M	0.02%	1021
2018 Q1	$251M	Sell	7,071,691 -119,080	-2%	-$4.66M	0.01%	1179
2017 Q4	$314M	Sell	7,190,771 -340,089	-5%	-$15.9M	0.01%	1047
2017 Q3	$394M	Buy	7,530,860 +1,068,961	+17%	+$59.6M	0.02%	811
2017 Q2	$378M	Buy	6,461,899 +2,917,605	+82%	+$152M	0.02%	811
2017 Q1	$163M	Buy	3,544,294 +3,535,568	+40,518%	+$176M	0.01%	1450
2016 Q4	$459K	Sell	8,726 -3,373	-28%	-$163K	﹤0.01%	1738
2016 Q3	$540K	Buy	12,099 +7,289	+152%	+$316K	﹤0.01%	1702
2016 Q2	$183K	Buy	4,810 +213	+5%	+$9.36K	﹤0.01%	2156
2016 Q1	$189K	Sell	4,597 -5,198	-53%	-$214K	﹤0.01%	1750
2015 Q4	$476K	Buy	9,795 +1,553	+19%	+$69.1K	﹤0.01%	1534
2015 Q3	$330K	Sell	8,242 -2,802	-25%	-$122K	﹤0.01%	1576
2015 Q2	$443K	Buy	+11,044	New	+$381K	﹤0.01%	1571

Other funds holding SYNH

Skandinaviska Enskilda Banken (SEB) Stockholm, Sweden $4.34B AUM 19.31% 1-Year Est. Return

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Natixis Advisors Boston, Massachusetts $71.9B AUM 28.03% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Nomura Asset Management Tokyo, Japan $38.8B AUM 30.94% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

BTI

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

CFB

Cullen/Frost Bankers San Antonio, Texas $10.1B AUM 29.18% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

BlackRock's SYNH Position: Q3 2023 in Review

BlackRock sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q3 2023, closing a stake of 9,930,430 shares — an estimated $418M sold.

BlackRock first reported a position in SYNH in Q2 2015 and held it in 33 quarters. The position peaked at $1.02B in Q4 2021. 10 funds tracked by Wall St. Rank hold SYNH as of Q3 2023.

BlackRock reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q3 2023 after selling out during the quarter.
BlackRock sold 9,930,430 Syneos Health, Inc. Class A Common Stock shares in Q3 2023, an estimated $418M.
BlackRock first reported a position in Syneos Health, Inc. Class A Common Stock in Q2 2015 and held it in 33 quarters.
BlackRock's Syneos Health, Inc. Class A Common Stock position peaked at $1.02B in Q4 2021.
10 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q3 2023.

Based on BlackRock's 13F filing for Q3 2023, filed 13 Nov 2023.